Yoshiaki Takemoto

2.8k total citations
128 papers, 2.0k citations indexed

About

Yoshiaki Takemoto is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yoshiaki Takemoto has authored 128 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Nephrology, 25 papers in Surgery and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yoshiaki Takemoto's work include Dialysis and Renal Disease Management (26 papers), Renal Transplantation Outcomes and Treatments (20 papers) and Organ Donation and Transplantation (13 papers). Yoshiaki Takemoto is often cited by papers focused on Dialysis and Renal Disease Management (26 papers), Renal Transplantation Outcomes and Treatments (20 papers) and Organ Donation and Transplantation (13 papers). Yoshiaki Takemoto collaborates with scholars based in Japan, France and Czechia. Yoshiaki Takemoto's co-authors include Tatsuya Nakatani, Toshihide Naganuma, Kenji Tsuchida, Rikio Yoshimura, Kazunobu Sugimura, Masahide Matsuyama, Yutaka Kawahito, Hajime Sano, Junji Uchida and Tadao Nakaya and has published in prestigious journals such as PLoS ONE, Biomaterials and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Yoshiaki Takemoto

120 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiaki Takemoto Japan 24 727 441 411 370 252 128 2.0k
André A. Kaplan United States 22 690 0.9× 346 0.8× 295 0.7× 174 0.5× 94 0.4× 70 1.7k
Bruno Memoli Italy 26 1.2k 1.7× 327 0.7× 524 1.3× 198 0.5× 247 1.0× 76 2.1k
Farid Nakhoul Israel 25 542 0.7× 889 2.0× 382 0.9× 140 0.4× 538 2.1× 83 2.6k
Reinhold Deppisch Germany 25 1.4k 2.0× 233 0.5× 557 1.4× 277 0.7× 189 0.8× 72 2.3k
Shigeru Nakai Japan 33 2.2k 3.0× 365 0.8× 726 1.8× 455 1.2× 303 1.2× 158 3.6k
Susanne Lang Germany 22 1.2k 1.6× 271 0.6× 466 1.1× 170 0.5× 466 1.8× 76 2.3k
David Taube United Kingdom 38 1.2k 1.7× 876 2.0× 1.3k 3.0× 252 0.7× 318 1.3× 151 4.5k
Ercan Ok Türkiye 29 1.7k 2.3× 325 0.7× 776 1.9× 380 1.0× 223 0.9× 104 2.8k
Randall Faull Australia 26 604 0.8× 278 0.6× 421 1.0× 186 0.5× 528 2.1× 67 2.4k
Felix Brunner Switzerland 27 775 1.1× 284 0.6× 703 1.7× 126 0.3× 308 1.2× 83 2.5k

Countries citing papers authored by Yoshiaki Takemoto

Since Specialization
Citations

This map shows the geographic impact of Yoshiaki Takemoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiaki Takemoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiaki Takemoto more than expected).

Fields of papers citing papers by Yoshiaki Takemoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiaki Takemoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiaki Takemoto. The network helps show where Yoshiaki Takemoto may publish in the future.

Co-authorship network of co-authors of Yoshiaki Takemoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiaki Takemoto. A scholar is included among the top collaborators of Yoshiaki Takemoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiaki Takemoto. Yoshiaki Takemoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirawa, Nobuhito, et al.. (2025). The present status of dialysis patients in Asian countries as of 2022 from a medical economic point of view. Renal Replacement Therapy. 11(1). 2 indexed citations
2.
Naganuma, Toshihide, Yoshikazu Kuroki, Tomoaki Iwai, Yoshiaki Takemoto, & Junji Uchida. (2024). Arteriovenous Fistula Closure Using a Simple Ligation Technique After Kidney Transplantation. Transplantation Proceedings. 56(3). 526–529.
3.
Naganuma, Toshihide, Yoshiaki Takemoto, N Kamada, et al.. (2024). Japanese Study of the Effects of AMG (α1-Microglobulin) Reduction Rates on Survival (JAMREDS): A Protocol of a Multicenter Prospective Observational Cohort Study. Blood Purification. 53(6). 527–532. 1 indexed citations
4.
Kikuchi, Kan, Masaomi Nangaku, Munekazu Ryuzaki, et al.. (2023). Efficacy of molnupiravir and sotrovimab in Japanese dialysis patients with COVID‐19 in clinical practice during the Omicron (BA.1 and BA.2) pandemic. Therapeutic Apheresis and Dialysis. 27(6). 1064–1069. 4 indexed citations
5.
Naganuma, Toshihide, Daijiro Kabata, Yoshiaki Takemoto, et al.. (2020). Selective plasma exchange in ABO-incompatible kidney transplantation: comparison of substitution with albumin and partial substitution with fresh frozen plasma. Scientific Reports. 10(1). 1434–1434. 8 indexed citations
6.
Uchida, Junji, Kazuya Kabei, Tomoaki Iwai, et al.. (2018). Favorable Outcomes of Elderly ABO-Incompatible Kidney Transplantation-Pilot Single Center Experience. Urologia Internationalis. 101(4). 459–466. 5 indexed citations
7.
Uchida, Junji, Kazuya Kabei, Tomoaki Iwai, et al.. (2017). Passenger Lymphocyte Syndrome in the ABO-Incompatible Kidney Transplant Recipient Receiving Rituximab. Experimental and Clinical Transplantation. 17(4). 558–560. 7 indexed citations
8.
Matsuyama, Masahide, et al.. (2007). POS-03.90: Anti-tumor effect of telmisartan (angiotensin II receptor blocker) in prostate cancer. Urology. 70(3). 300–300. 1 indexed citations
9.
Naganuma, Toshihide, Junji Uchida, Kenji Tsuchida, et al.. (2005). Silent cerebral infarction predicts vascular events in hemodialysis patients. Kidney International. 67(6). 2434–2439. 57 indexed citations
10.
Matsuyama, Masahide, R. Yoshimura, T. Hase, et al.. (2005). Expression of Peroxisome Proliferator-Activated Receptor-γ in Renal Ischemia-Reperfusion Injury. Transplantation Proceedings. 37(4). 1684–1685. 12 indexed citations
11.
Matsuyama, Masahide, Rikio Yoshimura, Makoto Mitsuhashi, et al.. (2004). Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. International Journal of Oncology. 24(4). 821–7. 71 indexed citations
12.
Naganuma, Toshihide, et al.. (2003). The Prognostic Role of Atrial Natriuretic Peptides in Hemodialysis Patients. Blood Purification. 21(6). 395–400. 11 indexed citations
13.
Tsuchida, Kenji, Yoshiaki Takemoto, Kazunobu Sugimura, et al.. (2002). Adsorption of Endotoxin by Beta2‐Microglobulin Adsorbent Column (Lixelle): The New Approach for Endotoxinemia. Therapeutic Apheresis. 6(2). 116–118. 14 indexed citations
14.
Tsuchida, Kenji, Yoshiaki Takemoto, Tatsuya Nakatani, et al.. (2000). Adsorption of Microorganism Components by Lixelle Beads. Artificial Organs. 24(7). 577–580. 11 indexed citations
15.
Sawai, Kiyoshi, et al.. (1996). Rationale of lymph node dissection for breast cancer--from the viewpoint of analysis of axillary lymphatic flow using activated carbon particle CH40.. PubMed. 23 Suppl 1. 30–5. 3 indexed citations
16.
Tanaka, Hiroshi, et al.. (1995). Clinical effects of azelastine hydrochloride in hemodialysis patients with pruritus cutaneous.. Nihon Toseki Igakkai Zasshi. 28(4). 389–395. 1 indexed citations
17.
Sugimura, Kazunobu, Tsuyoshi Goto, Yoshiaki Takemoto, et al.. (1995). Serum Hepatocyte Growth Factor Levels in Patients with Chronic Renal Failure. ˜The œNephron journals/Nephron journals. 70(3). 324–328. 32 indexed citations
18.
Ito, Shunsuke, et al.. (1992). Peptidyl Antithrombogenic Agents for Extracorporeal Blood Circulation. The International Journal of Artificial Organs. 15(12). 737–745. 1 indexed citations
19.
Masaoka, T, et al.. (1991). Phase II study of FK 506 for allogeneic bone marrow transplantation.. PubMed. 23(6). 3228–31. 21 indexed citations
20.
Takemoto, Yoshiaki, et al.. (1990). The evaluation of the interaction of platelet/artificial dialyzer membrane based on intracellular calcium ion mobilization. 19(2). 727–730. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André A. Kaplan Breakdown of academic impact, for papers by Bruno Memoli Breakdown of academic impact, for papers by Farid Nakhoul Breakdown of academic impact, for papers by Reinhold Deppisch Breakdown of academic impact, for papers by Shigeru Nakai Breakdown of academic impact, for papers by Susanne Lang Breakdown of academic impact, for papers by David Taube Breakdown of academic impact, for papers by Ercan Ok Breakdown of academic impact, for papers by Randall Faull Breakdown of academic impact, for papers by Felix Brunner
Rankless by CCL
2026